Skip to Main Content

Paper Details

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.
Nat Commun
27
2021
Author NameAffiliation
Martin L SosInstitute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne
Martin L SosFaculty of Medicine and University Hospital Cologne, University of Cologne
Martin L SosCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne
  • 1 - 3

Datasets

Release 1.2